Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Docmorris-Konkurrent Redcare Pharmacy schafft weiteren Umsatzsprung (Cash) +++ REDCARE Aktie +4,64%

ARMATA Aktie

>ARMATA Performance
1 Woche: 0%
1 Monat: -5,7%
3 Monate: +14,7%
6 Monate: -14,6%
1 Jahr: -31,7%
laufendes Jahr: -14,6%
>ARMATA Aktie
Name:  ARMATA PHARMACEUT.
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US04216R1023 / A2PKLC
Symbol/ Ticker:  TG1N (Frankfurt)
Kürzel:  FRA:TG1N, ETR:TG1N, TG1N:GR
Index:  -
Webseite:  https://www.armatapharma...
Marktkapitalisierung:  58.35 Mio. EUR
Umsatz:  4.07 Mio. EUR
EBITDA:  -33.77 Mio. EUR
Gewinn je Aktie:  -0.294 EUR
Schulden:  116.59 Mio. EUR
Liquide Mittel:  10.12 Mio. EUR
Umsatz-/ Gewinnwachstum:  -49.2% / -
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  - / 2.39 / -
Gewinnm./ Eigenkapitalr.:  -9.07% / -
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  ARMATA
Letzte Datenerhebung:  03.07.25
>ARMATA Eigentümer
Aktien: 36.19 Mio. St.
f.h. Aktien: 11.02 Mio. St.
Insider Eigner: 69.59%
Instit. Eigner: 2.05%
Leerverk. Aktien: -
>ARMATA Peer Group

 
21.05.25 - 17:30
ARMP Soars 72% in a Month Following Infectious Disease Study Success (Zacks)
 
Armata Pharmaceuticals stock surges 72% in a month following superior efficacy results from a phase Ib/IIa study of AP-SA02 for treating an infectious disease....
19.05.25 - 13:01
Armata Pharmaceuticals Announces Positive Topline Data from the Phase 1b/2a diSArm Study of Intravenously Administered AP-SA02 in Complicated Staphylococcus aureus Bacteremia (PR Newswire)
 
All primary endpoints for safety, tolerability, and clinical response in the intent-to-treat population met AP-SA02 arm significantly improved clinical outcomes and prevented relapse compared to best available antibiotic therapy No treatment-related serious adverse events were observed......
15.05.25 - 01:00
Armata Pharmaceuticals, Inc. (ARMP) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
 
Armata Pharmaceuticals (ARMP) delivered earnings and revenue surprises of 47.37% and 64.42%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?...
14.05.25 - 22:09
Armata Pharmaceuticals Announces First Quarter 2025 Results and Provides Corporate Update (PR Newswire)
 
LOS ANGELES, May 14, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of......
01.05.25 - 13:06
Armata Pharmaceuticals Receives $4.65 Million of Additional Non-Dilutive Award Funding from the U.S. Department of Defense to Support Ongoing diSArm Clinical Trial of AP-SA02 (PR Newswire)
 
Phase 1b/2a diSArm trial evaluated AP-SA02 as a potential treatment for complicated Staphylococcus aureus bacteremia Topline data anticipated in Q2 2025 to support potential future pivotal bacteremia efficacy trial LOS ANGELES, May 1, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc.......
21.03.25 - 06:18
Armata Pharmaceuticals GAAP EPS of -$0.23, revenue of $1.2M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
20.03.25 - 23:00
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2024 Results and Provides Corporate Update (PR Newswire)
 
LOS ANGELES, March 20, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of......
12.03.25 - 22:18
Armata Pharmaceuticals announces $10M secured credit agreement with Innoviva (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
12.03.25 - 22:12
Armata Pharmaceuticals Announces $10 Million Secured Credit Agreement with Innoviva (PR Newswire)
 
Proceeds to be used to continue to advance development of Armata's phage product candidates LOS ANGELES, March 12, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of......
11.03.25 - 12:03
Armata Pharmaceuticals Announces that CEO Dr. Deborah Birx Will Deliver a Presentation at the 7th Annual Bacteriophage Therapy Summit (PR Newswire)
 
LOS ANGELES, March 11, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity pathogen-specific bacteriophage therapeutics for the treatment of......
14.11.24 - 00:48
Armata Pharmaceuticals, Inc. (ARMP) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
 
Armata Pharmaceuticals (ARMP) delivered earnings and revenue surprises of 46.43% and 230.33%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?...
14.11.24 - 00:06
Armata Pharmaceuticals GAAP EPS of -$0.15 beats by $0.13 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
13.11.24 - 22:07
Armata Pharmaceuticals Announces Third Quarter 2024 Results and Provides Corporate Update (PR Newswire)
 
LOS ANGELES, Nov. 13, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on high-purity, pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections,......
12.09.24 - 19:33
Armata Pharmaceuticals (ARMP) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
 
Armata Pharmaceuticals (ARMP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term....
15.08.24 - 22:45
Armata Pharmaceuticals Announces Appointment of Life Sciences Accounting and Finance Veteran David House as SVP of Finance and Principal Financial Officer (PR Newswire)
 
LOS ANGELES, Aug. 15, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat......
14.08.24 - 16:42
Armata Pharmaceuticals GAAP EPS of -$0.25 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
13.08.24 - 22:07
Armata Pharmaceuticals Announces Second Quarter 2024 Results and Provides Corporate Update (PR Newswire)
 
LOS ANGELES, Aug. 13, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on high-purity, pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections,......
30.07.24 - 17:06
This WWII Soviet Tank Laid the Foundation For Russia’s Modern Tank Program (24/7 Wall St.)
 
24/7 Wall St. Insights: The Soviet Union's T-34 tanks won an impressive victory in Kursk The T-54 and T-55 were some of the most mass-produced tanks ever The T-14 Armata is the next generation of Russian tank Also: Discover the next Nvidia In the years between World War I and World War II, the Soviet […] The post This WWII Soviet Tank Laid the Foundation For Russia’s Modern Tank Program appeared first on 24/7 Wall St.....
29.07.24 - 17:24
This Russian Tank Has Bigger Guns Than the M1 Abrams (24/7 Wall St.)
 
24/7 Wall St. Insights: The T-14 Armata is the newest Russian tank to enter service It has a 125mm smoothbore cannon that is bigger than the American M1 Abrams Russia's history as holding a strong tank army extends as far back as WWII Also: Discover the next Nvidia Russia's newest main battle tank is formidable, […] The post This Russian Tank Has Bigger Guns Than the M1 Abrams appeared first on 24/7 Wall St.....
27.07.24 - 17:48
This New Russian Tank Can Reach 55 MPH (24/7 Wall St.)
 
24/7 Wall St. Insights: Russia has a long, storied history of tank warfare Post-WWII Russia's tanks made a huge breakthrough in their design The T-99 Armata is one of the newest and most advanced Russian tanks Also: Discover the next Nvidia The history of Russian tanks began in the time between World War I and […] The post This New Russian Tank Can Reach 55 MPH appeared first on 24/7 Wall St.....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Der guckt die Bälle weg. - Fritz Walter
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!